Mavens Biotech Ltd. - Research Center
590083 MAVENSBIO Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 16 | Mar ' 15 | Mar ' 14 | Mar ' 13 | Mar ' 12 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 8.23 | 8.15 | 8.12 | 8.05 | 7.35 |
| Loan funds | |||||
| Secured loans | - | - | - | - | - |
| Unsecured loans | - | - | - | - | - |
| Total | 19.22 | 19.14 | 19.11 | 19.05 | 18.34 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 7.26 | 7.25 | 7.25 | 7.25 | 7.25 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 3.03 | 2.88 | 2.51 | 2.29 | 2.01 |
| Net block | 4.22 | 4.37 | 4.74 | 4.96 | 5.24 |
| Capital work-in-progress | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 |
| Investments | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| Net current assets | |||||
| Current assets, loans & advances | 13.48 | 13.22 | 12.81 | 12.61 | 11.69 |
| Less : current liabilities & provisions | 0.34 | 0.31 | 0.30 | 0.38 | 0.45 |
| Total net current assets | 13.14 | 12.91 | 12.51 | 12.23 | 11.24 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 19.22 | 19.14 | 19.11 | 19.05 | 18.34 |
| Notes: | |||||
| Book value of unquoted investments | - | - | 0.42 | 0.42 | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 1.35 | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 1099.20 | 1099.20 | 1099.20 | 1099.20 | 1099.20 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis